NCT02771990

Brief Summary

The goal of this study is to investigate the role of central neural pathways in mediating chronic pain. The aim of the study is to test the effect of stimulating brain regions that are part of a network underlying central pain processing using a non-invasive brain stimulation technique, transcranial Direct Current Stimulation (tDCS). Prior studies have used tDCS to target both sensory related cortical areas and those important for higher-order representations of pain. This study will target brain regions important for the behavioral response to the chronic sensation of pain. The hypothesis is that stimulation of these brain regions can modulate not only the affective component of pain, but ultimately also improve functioning and quality of life. This hypothesis will be tested by treating study participants eighteen and older with chronic low back pain (CLBP) of greater than six months using tDCS. To be part of this study, participants must meet all the inclusion and exclusion criteria.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2013

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2013

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

May 12, 2016

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 13, 2016

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 3, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 3, 2018

Completed
3.1 years until next milestone

Results Posted

Study results publicly available

May 4, 2021

Completed
Last Updated

March 29, 2023

Status Verified

March 1, 2023

Enrollment Period

4.5 years

First QC Date

May 12, 2016

Results QC Date

October 10, 2019

Last Update Submit

March 27, 2023

Conditions

Keywords

Back Pain

Outcome Measures

Primary Outcomes (2)

  • West Haven-Yale Multidimensional Pain Inventory (WHY-MPI) General Activity Subscale Rating

    The WHY-MPI General Activity subscale contains 18 items summed to give a score ranging from 0 to 108 (higher scores indicate more activity \[better\]).

    8 weeks

  • Pain Anxiety Symptom Scale (PASS-20) Rating

    The PASS-20 contains 20 items and scores could range from 0 to 100 (higher scores indicate greater pain anxiety).

    8 weeks

Study Arms (2)

sham tDCS

SHAM COMPARATOR

10 sessions sham transcranial direct current stimulation (tDCS)

Device: Sham transcranial direct current stimulation

active tDCS

EXPERIMENTAL

10 sessions active transcranial direct current stimulation (tDCS)

Device: transcranial direct current stimulation

Interventions

sham stimulation

sham tDCS

2 milliamp (mA) 20 minutes

active tDCS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Chronic Low Back Pain ≥ 6 months duration in the lumbar region, present more than half the days of the month, and on average be at a moderate level of severity in the last month
  • At least one trial of physician recommended medication (e.g. acetaminophen, NSAIDS, skeletal muscle relaxants)
  • Pre-existing opioid and non-opioid pain medication must be non-existent or stable (medications have not changed for one month)
  • Be able to understand, read and write English
  • If female and of childbearing age, agree to use acceptable birth control during the study treatment period (oral contraceptives, history of tubal ligation, history of a hysterectomy, or a reliable barrier method)

You may not qualify if:

  • Lifetime Diagnostic and Statistical Manual (DSM) IV diagnosis of bipolar disorder, schizophrenia, or other chronic psychotic condition
  • Current DSM-IV diagnosis of substance dependence for alcohol, sedative/hypnotic drugs, stimulants, cocaine
  • Current cancer, infection, or inflammatory arthritis
  • Broken skin or other lesions in the area of the electrodes
  • Uncontrolled medical problems, such as diabetes mellitus, hypertension, pulmonary or airway disease, heart failure, coronary artery disease, or any other condition that poses a risk for the subject during participation
  • Presence of metal in the cranial cavity
  • Holes in the skull made by trauma or surgery
  • Pacemakers, medication pumps, and other implanted electronic hardware
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Back Pain

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Limitations and Caveats

small sample size (N = 21), participants were not stratified by premorbid anxiety levels, inability to guarantee optimal targeting of the left dorsal anterior cingulate cortex, inability to address laterality effects of pain perception

Results Point of Contact

Title
Benjamin Greenberg
Organization
Providence Veterans Affairs Medical Center

Study Officials

  • Frederick Burgess, MD, PhD

    Providence VA Medical Center

    PRINCIPAL INVESTIGATOR
  • Benjamin Greenberg, MD, PhD

    Providence VA Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Director, CfNN

Study Record Dates

First Submitted

May 12, 2016

First Posted

May 13, 2016

Study Start

October 1, 2013

Primary Completion

April 3, 2018

Study Completion

April 3, 2018

Last Updated

March 29, 2023

Results First Posted

May 4, 2021

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Only de-identified data will be shared.